Mature results from Hoosier Oncology Group GU04-75 phase II trial of cisplatin (C), gemcitabine (G), and bevacizumab (B) as first-line chemotherapy for metastatic urothelial carcinoma (UC)

Authors :: Christopher Sweeney
M. J. Waddell
Susan M. Perkins
Joel Picus
Cynthia S. Johnson
Robin Zon
N. M. Hahn
David M. Waterhouse
Walter M. Stadler
Sreenivasa Nattam
Source :: Journal of Clinical Oncology. 28:4541-4541
Publication Year :: 2010
Publisher :: American Society of Clinical Oncology (ASCO), 2010.
Abstract: 4541 Background: Initial results of CGB therapy in metastatic UC patients demonstrated encouraging response and overall survival results with concerning rates of toxicity (Hahn et al ASCO 2008, abs...

Subjects :: Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
Metastatic Urothelial Carcinoma
Bevacizumab
business.industry
Gemcitabine
Internal medicine
Toxicity
medicine
Overall survival
First line chemotherapy
business
medicine.drug

Full Text Access

Tools